Concepedia

Ricardo J. Samms

RJ

Statistics

Publications

27

Citations

1.5K

H-Index

18

Active since

2012

Affiliations

Eli Lilly (United States)(Current)

Queen's Medical Centre

University of Nottingham

University of Pennsylvania

The University of Texas Southwestern Medical Center

Ricardo J. Samms is an author at Eli Lilly (United States) specializing in life sciences, metabolic regulation, and adipose tissue.

ORCID

Publications per year

2012–2025

27

Publications

27

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

Ricardo J. Samms, Michael E. Christe, Kyla Collins et al. · Journal of Clinical Investigation · 2021 · 227 citations · Full text

, , +17

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models

Tito Borner, Caroline E. Geisler, Samantha M. Fortin et al. · Diabetes · 2021 · 180 citations · Full text

, , +17

Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1

Ricardo J. Samms, Dennis P. Smith, Christine C. Cheng et al. · Cell Reports · 2015 · 149 citations · Full text

, , +15

Serum FGF21 levels are associated with brown adipose tissue activity in humans

Mark J. W. Hanssen, Evie P. M. Broeders, Ricardo J. Samms et al. · Scientific Reports · 2015 · 137 citations · Full text

, , +15

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue

Ricardo J. Samms, Guofang Zhang, Wentao He et al. · Molecular Metabolism · 2022 · 82 citations · Full text

, , +17

1–5 of 27